Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with Boston Keratoprosthesis type 1

Samir Jabbour, Mark R. Lesk, Mona Harissi-Dagher

Research output: Contribution to journalArticle

Abstract

Purpose: To report the first successfully treated case of recurrent tube exposure in a patient with the Boston Keratoprosthesis type 1 with a collagen matrix patch graft (Ologen). Observations: A 50 year-old female with a Boston Keratoprosthesis type 1 and a history of Axenfeld-Reiger syndrome presents to our department with recurrent glaucoma drainage device exposure in her left eye. After failed spontaneous closure with topical antibiotics and lubricants, she undergoes tube exposure repair using an Ologen patch graft. Surgery was successful and the patient did not have any recurrence up to last follow-up two years post-operatively. Conclusion: Collagen matrix patch graft seems to be advantageous in treating glaucoma tube exposure in the Boston KPro eye, which is often a more challenging entity to treat. Importance: Collagen matrix patch graft could be considered as a primary patch graft in treating tube exposure in eyes with the Boston KPro.

Original languageEnglish (US)
Pages (from-to)32-35
Number of pages4
JournalAmerican Journal of Ophthalmology Case Reports
Volume12
DOIs
StatePublished - Dec 1 2018
Externally publishedYes

Fingerprint

Glaucoma
Drainage
Collagen
Transplants
Equipment and Supplies
Lubricants
collagen-glycosaminoglycan copolymer
Anti-Bacterial Agents
Recurrence

Keywords

  • Boston Kpro
  • Glaucoma drainage device
  • Ologen
  • Tube exposure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with Boston Keratoprosthesis type 1. / Jabbour, Samir; Lesk, Mark R.; Harissi-Dagher, Mona.

In: American Journal of Ophthalmology Case Reports, Vol. 12, 01.12.2018, p. 32-35.

Research output: Contribution to journalArticle

@article{a4b5bf53468d4fc2b9d626f22155e88e,
title = "Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with Boston Keratoprosthesis type 1",
abstract = "Purpose: To report the first successfully treated case of recurrent tube exposure in a patient with the Boston Keratoprosthesis type 1 with a collagen matrix patch graft (Ologen). Observations: A 50 year-old female with a Boston Keratoprosthesis type 1 and a history of Axenfeld-Reiger syndrome presents to our department with recurrent glaucoma drainage device exposure in her left eye. After failed spontaneous closure with topical antibiotics and lubricants, she undergoes tube exposure repair using an Ologen patch graft. Surgery was successful and the patient did not have any recurrence up to last follow-up two years post-operatively. Conclusion: Collagen matrix patch graft seems to be advantageous in treating glaucoma tube exposure in the Boston KPro eye, which is often a more challenging entity to treat. Importance: Collagen matrix patch graft could be considered as a primary patch graft in treating tube exposure in eyes with the Boston KPro.",
keywords = "Boston Kpro, Glaucoma drainage device, Ologen, Tube exposure",
author = "Samir Jabbour and Lesk, {Mark R.} and Mona Harissi-Dagher",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.ajoc.2018.08.003",
language = "English (US)",
volume = "12",
pages = "32--35",
journal = "American Journal of Ophthalmology Case Reports",
issn = "2451-9936",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with Boston Keratoprosthesis type 1

AU - Jabbour, Samir

AU - Lesk, Mark R.

AU - Harissi-Dagher, Mona

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Purpose: To report the first successfully treated case of recurrent tube exposure in a patient with the Boston Keratoprosthesis type 1 with a collagen matrix patch graft (Ologen). Observations: A 50 year-old female with a Boston Keratoprosthesis type 1 and a history of Axenfeld-Reiger syndrome presents to our department with recurrent glaucoma drainage device exposure in her left eye. After failed spontaneous closure with topical antibiotics and lubricants, she undergoes tube exposure repair using an Ologen patch graft. Surgery was successful and the patient did not have any recurrence up to last follow-up two years post-operatively. Conclusion: Collagen matrix patch graft seems to be advantageous in treating glaucoma tube exposure in the Boston KPro eye, which is often a more challenging entity to treat. Importance: Collagen matrix patch graft could be considered as a primary patch graft in treating tube exposure in eyes with the Boston KPro.

AB - Purpose: To report the first successfully treated case of recurrent tube exposure in a patient with the Boston Keratoprosthesis type 1 with a collagen matrix patch graft (Ologen). Observations: A 50 year-old female with a Boston Keratoprosthesis type 1 and a history of Axenfeld-Reiger syndrome presents to our department with recurrent glaucoma drainage device exposure in her left eye. After failed spontaneous closure with topical antibiotics and lubricants, she undergoes tube exposure repair using an Ologen patch graft. Surgery was successful and the patient did not have any recurrence up to last follow-up two years post-operatively. Conclusion: Collagen matrix patch graft seems to be advantageous in treating glaucoma tube exposure in the Boston KPro eye, which is often a more challenging entity to treat. Importance: Collagen matrix patch graft could be considered as a primary patch graft in treating tube exposure in eyes with the Boston KPro.

KW - Boston Kpro

KW - Glaucoma drainage device

KW - Ologen

KW - Tube exposure

UR - http://www.scopus.com/inward/record.url?scp=85051814533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051814533&partnerID=8YFLogxK

U2 - 10.1016/j.ajoc.2018.08.003

DO - 10.1016/j.ajoc.2018.08.003

M3 - Article

VL - 12

SP - 32

EP - 35

JO - American Journal of Ophthalmology Case Reports

JF - American Journal of Ophthalmology Case Reports

SN - 2451-9936

ER -